AlzeCure Pharma: AlzeCure gets New Abstract Accepted on ACD856's Indicative Disease-Modifying Effects Against Alzheimer's
STOCKHOLM, SE / ACCESSWIRE / October 18, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
Source: finanznachrichten.de